Risk stratification is essential in Barrett’s esophagus surveillance to identify patients at higher risk of progression to esophageal adenocarcinoma. While histopathology remains the cornerstone of diagnosis and management, newer adjunctive techniques aim to improve dysplasia detection and refine risk assessment. Here is a quick question to test your understanding of emerging tools in Barrett’s esophagus surveillance! (Scroll down to answer the question) ##Reference## Singer ME, Smith MS. Wide Area Transepithelial Sampling with Computer-Assisted Analysis (WATS3D) Is Cost-Effective in Barrett's Esophagus Screening. Dig Dis Sci.
2021 May;66(5):1572-1579. doi: 10.1007/s10620-020-06412-1. Epub 2020 Jun 23. PMID: 32578042; PMCID: PMC8053177.## ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no…
